2022 annual financial data

Protagonist Therapeutics 2022 Net margin

Direct answer

Net margin was -464.29%.

Operating income was -131,373,000 USD and net income was -123,413,000 USD.
Operating cash flow was -108,137,000 USD.

Get free Protagonist Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
26,581,000 USD
Operating income
-131,373,000 USD
Net income
-123,413,000 USD
Operating cash flow
-108,137,000 USD